Viewing StudyNCT00034879



Ignite Creation Date: 2024-05-05 @ 11:26 AM
Last Modification Date: 2024-10-26 @ 9:07 AM
Study NCT ID: NCT00034879
Status: COMPLETED
Last Update Posted: 2013-01-04
First Post: 2002-05-02

Brief Title: Iressa Expanded Access Program EAP
Sponsor: AstraZeneca
Organization: AstraZeneca

Conditions & Keywords Data

Conditions:
Name
Neoplasm
Carcinoma
Non-small-cell Lung
Metastases
Keywords:
Name View
patients who have failed standard therapy View
Locally advanced andor metastatic non-operable View
non-small cell lung cancer stage III or IV View